Dadun Dadun cabecera universidad cabecera biblioteca
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > Clínica Universidad de Navarra > Cirugía general y digestiva > DA - CUN - Cirugía general y digestiva - Artículos de revista >

Conversion From Calcineurin Inhibitors to Mycophenolate Mofetil in Liver Transplant Recipients With Diabetes Mellitus
Authors: Herrero, J.I. (José Ignacio)
Quiroga, J. (Jorge)
Sangro, B. (Bruno)
Pardo, F. (Fernando)
Rotellar, F. (Fernando)
Cienfuegos, J.A. (Javier A.)
Prieto, J. (Jesús)
Keywords: Cyclosporine/adverse effects/therapeutic use
Diabetes Mellitus/blood/immunology
Graft Rejection/drug therapy/epidemiology
Issue Date: 2003
Publisher: Elsevier
Publisher version: http://ac.els-cdn.com/S0041134503006444/1-s2.0-S0041134503006444-main.pdf?_tid=61297ce1fc309e380449ce9cdb5a2bd9&acdnat=1342092791_fd163271f2e5a16d47bc622e5693634e
ISSN: 0041-1345
Citation: Herrero JI, Quiroga J, Sangro B, Pardo F, Rotellar F, Cienfuegos JA, Prieto J. Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus.Transplant Proc. 2003 Aug;35(5):1877-9.
Abstract
Diabetes mellitus, a frequent metabolic complication in liver transplant recipients, may be produced by the diabetogenic effect of calcineurin inhibitors cyclosporine and tacrolimus. The aim of this study was to investigate the safety and metabolic effects of a gradual switch from cyclosporine or tacrolimus to mycophenolate mofetil among 12 diabetic liver transplant recipients. One patient was withdrawn from the study due to gastrointestinal side effects. Of the 11 remaining patients, cyclosporine or tacrolimus was completely withdrawn in five patients. Two patients developed suspected acute rejection episodes that were controlled by increasing the tacrolimus dosage. Glycosylated hemoglobin A1C and C-peptide levels were significantly lower at 3 and 6 months after the initiation of mycophenolate mofetil (P<.03 in all cases). Furthermore, urea and uric acid levels were significantly reduced after the change of treatment. In conclusion, a switch from cyclosporine/tacrolimus to mycophenolate mofetil may produce beneficial metabolic effects in diabetic liver transplant recipients, but poses a risk of graft rejection.
Permanent link: http://hdl.handle.net/10171/23180
Appears in Collections:DA - CUN - Cirugía general y digestiva - Artículos de revista

Files in This Item:
File:  Transplant proc 2003. 1877.pdf
Description: 
Size:  47,79 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.